AGL

AGL EV/EBITDA

-6.06×TTM

Retrieved:

AGL FY EV/EBITDA
AGL FY EV/EBITDA35.14×-332.14×
2019-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

AGL ev/ebitda history

Enterprise value to EBITDA ratio. The available annual fiscal periods series contains 7 observations from Dec 31, 2019 to Dec 31, 2025.

Agilon Health EV/EBITDA — Annual fiscal periods
Period endingEV/EBITDA
-0.4019×
-2.8917×
-30.2422×
-85.2719×
-25.055×
-296.6004×
-184.7017×

Compare ev/ebitda

All AGL financial metrics · AGL stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.